Asset Allocation
Find the right asset allocation for 22526-2
Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio OptimizerPerformance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in 22526-2, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.
Loading charts...
Returns By Period
| Position | 1D | 1M | YTD | 6M | 1Y | 3Y* | 5Y* | 10Y* |
|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | 1.65% | 1.97% | 10.35% | 10.82% | 26.39% | 19.66% | 12.33% | 13.81% |
Portfolio 22526-2 | 0.95% | 1.83% | 9.55% | 10.38% | 42.17% | — | — | — |
| Portfolio components: | ||||||||
ALKS Alkermes plc | 0.18% | 18.36% | 58.54% | 57.47% | 48.71% | 11.28% | 12.07% | 0.70% |
CMPS COMPASS Pathways plc | -2.40% | 13.69% | 70.87% | 78.91% | 168.56% | 15.31% | -20.57% | — |
DFTX Definium Therapeutics, Inc | -3.96% | 13.24% | 77.52% | 96.77% | 231.52% | 84.74% | — | — |
ENVB Enveric Biosciences Inc | -3.27% | -34.22% | -59.23% | -72.39% | -89.81% | -87.52% | -85.10% | -74.86% |
FMED Fidelity Disruptive Medicine ETF | 0.90% | 7.10% | -4.75% | -6.17% | 8.53% | 0.73% | — | — |
FRNW Fidelity Clean Energy ETF | 0.40% | -4.24% | 23.62% | 23.50% | 63.53% | 6.49% | — | — |
GDX VanEck Gold Miners ETF | 6.55% | -2.38% | -0.58% | 1.22% | 57.71% | 41.18% | 19.97% | 13.81% |
IBBQ Invesco Nasdaq Biotechnology ETF | 0.54% | 2.51% | 4.83% | 4.79% | 40.36% | 13.02% | 4.49% | — |
ICLN iShares Global Clean Energy ETF | 0.80% | -3.23% | 28.34% | 28.17% | 61.48% | 5.46% | -0.17% | 11.52% |
MLI Mueller Industries, Inc. | -0.25% | 1.23% | 20.69% | 20.88% | 87.45% | 52.10% | 45.38% | 26.81% |
Monthly Returns
Based on dividend-adjusted daily data since Feb 22, 2024, 22526-2's average daily return is +0.12%, while the average monthly return is +2.49%. At this rate, an investment would double in approximately 2.3 years.
Historically, 76% of months were positive and 24% were negative. The best month was Aug 2025 with a return of +10.3%, while the worst month was Mar 2026 at -8.1%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 1 months.
On a daily basis, 22526-2 closed higher 59% of trading days. The best single day was Apr 9, 2025 with a return of +7.1%, while the worst single day was Apr 4, 2025 at -6.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.76% | 8.47% | -8.06% | 1.83% | 2.43% | -1.35% | 9.55% | ||||||
| 2025 | 5.99% | 1.54% | 3.00% | -1.81% | 3.09% | 3.29% | 0.72% | 10.33% | 8.15% | -0.72% | 6.38% | 2.43% | 50.70% |
| 2024 | 0.44% | 9.32% | -1.21% | 6.11% | -1.99% | 7.40% | 2.48% | 1.94% | 0.52% | 1.50% | -6.77% | 20.40% |
Benchmark Metrics
22526-2 has an annualized alpha of 19.39%, beta of 0.71, and R2 of 0.41 versus S&P 500 Index. Calculated based on daily prices since February 22, 2024.
- This portfolio captured 117.48% of S&P 500 Index gains but only 21.24% of its losses - a favorable profile for investors.
- R2 of 0.41 means the benchmark explains less than half of this portfolio's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 19.39%
- Beta
- 0.71
- R²
- 0.41
- Upside Capture
- 117.48%
- Downside Capture
- 21.24%
Expense Ratio
22526-2 has an expense ratio of 0.38%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Top 10 holdings
Return for Risk
Risk / Return Rank
22526-2 ranks 54 for risk / return — on par with similar Portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below presents risk-adjusted performance metrics for 22526-2 and compares them with S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| Portfolio | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 2.23 | 2.14 | +0.10 |
| Sortino ratioReturn per unit of downside risk | 2.71 | 2.89 | -0.18 |
| Omega ratioGain probability vs. loss probability | 1.39 | 1.39 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 3.24 | 2.91 | +0.32 |
| Martin ratioReturn relative to average drawdown | 10.27 | 13.08 | -2.81 |
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Position | Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio |
|---|---|---|---|---|---|---|
ALKS Alkermes plc | 76 | 1.20 | 1.92 | 1.24 | 2.21 | 5.11 |
CMPS COMPASS Pathways plc | 85 | 1.64 | 2.36 | 1.36 | 3.32 | 9.89 |
DFTX Definium Therapeutics, Inc | 96 | 3.76 | 3.85 | 1.45 | 9.40 | 29.57 |
ENVB Enveric Biosciences Inc | 11 | -0.51 | -1.01 | 0.87 | -0.98 | -1.34 |
FMED Fidelity Disruptive Medicine ETF | 15 | 0.44 | 0.79 | 1.09 | 0.47 | 1.03 |
FRNW Fidelity Clean Energy ETF | 79 | 2.37 | 2.98 | 1.37 | 4.50 | 15.55 |
GDX VanEck Gold Miners ETF | 35 | 1.23 | 1.65 | 1.23 | 1.60 | 4.39 |
IBBQ Invesco Nasdaq Biotechnology ETF | 74 | 2.02 | 2.85 | 1.33 | 4.86 | 15.49 |
ICLN iShares Global Clean Energy ETF | 73 | 2.19 | 2.75 | 1.35 | 3.77 | 13.82 |
MLI Mueller Industries, Inc. | 92 | 2.93 | 3.44 | 1.50 | 3.94 | 10.92 |
Loading charts...
Dividends
Dividend yield
22526-2 provided a 2.59% dividend yield over the last twelve months.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 2.59% | 2.93% | 2.90% | 2.63% | 2.35% | 2.44% | 2.90% | 2.35% | 2.52% | 2.57% | 1.43% | 2.67% |
| Portfolio components: | ||||||||||||
ALKS Alkermes plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CMPS COMPASS Pathways plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DFTX Definium Therapeutics, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FRNW Fidelity Clean Energy ETF | 1.02% | 1.25% | 1.43% | 1.30% | 0.69% | 0.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GDX VanEck Gold Miners ETF | 0.74% | 0.74% | 1.19% | 1.61% | 1.66% | 1.67% | 0.53% | 0.67% | 0.50% | 0.76% | 0.26% | 0.85% |
IBBQ Invesco Nasdaq Biotechnology ETF | 0.84% | 0.90% | 1.14% | 0.81% | 0.76% | 0.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ICLN iShares Global Clean Energy ETF | 1.54% | 1.63% | 1.85% | 1.59% | 0.89% | 1.18% | 0.34% | 1.36% | 2.77% | 2.49% | 3.88% | 2.36% |
MLI Mueller Industries, Inc. | 0.87% | 0.87% | 1.01% | 1.27% | 1.69% | 0.88% | 1.14% | 1.26% | 1.71% | 9.60% | 0.94% | 1.11% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the 22526-2. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the 22526-2 was 13.09%, occurring on Mar 20, 2026. The portfolio has not yet recovered.
The current 22526-2 drawdown is 6.30%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 correction2026 | -13.09%Mar 2026 | 18d | — | 3mo 16dMar 2026 - now |
2025 selloff2025 | -11.87%Apr 2025 | 5d | 1mo 11d | 1mo 16dApr 2025 - May 2025 |
2024 pullback2024 | -9.13%Dec 2024 | 1mo 27d | 1mo 26d | 3mo 23dOct 2024 - Feb 2025 |
2026 pullback2026 | -6.91%Feb 2026 | 7d | 21d | 28dJan 2026 - Feb 2026 |
2024 pullback2024 | -6.53%Aug 2024 | 21d | 12d | 1mo 3dJul 2024 - Aug 2024 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 23 assets, with an effective number of assets of 3.29, reflecting the diversification based on asset allocation. Your portfolio is dominated by one or two holdings, which significantly increases concentration risk. Consider rebalancing toward more even weights or adding additional positions.
Diversification Ratio
1Y | All Time | |
|---|---|---|
Diversification Ratio | 1.38 | 1.40 |
The portfolio has a diversification ratio of 1.40, in line with the typical range across portfolios. There's room to improve by adding less correlated assets.
22526-2 correlation to the S&P 500 Index
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since Feb 22, 2024 | 0.54 |
Benchmark Correlations
Correlation vs. S&P 500 Index. VOO has the highest benchmark correlation at 1.00, while OUNZ has the lowest at 0.16.
Portfolio Correlations
Correlation vs. 22526-2. GDX has the highest portfolio correlation at 0.83, while ENVB has the lowest at 0.19.
Asset Correlations Table
Find what 22526-2 is missing
See which holdings overlap, where 22526-2 is concentrated, and which low-correlation assets could fill the gaps.
Analyze Diversification